Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Authors

  • Eva Tiensuu Janson Department of Medical Sciences, Endocrine Oncology Uppsala University, Uppsala, Sweden
  • Ulrich Knigge Departments of Surgery C and Endocrinology PE, Faculty of Health Science, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark
  • Gitte Dam Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark
  • Birgitte Federspiel Department of Pathology, Faculty of Health Science, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
  • Henning Grønbaek Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark
  • Peter Stålberg Department of Surgical Sciences, Endocrine Surgery, Uppsala University, Uppsala, Sweden
  • Seppo W. Langer Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
  • Andreas Kjaer Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet, Copenhagen, Denmark; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Johanna Arola Department of Pathology, HUSLAB, Helsinki University and Helsinki University Central Hospital, Helsinki, Finland
  • Camilla Schalin-Jäntti Endocrinology, Abdominal Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
  • Anders Sundin Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden
  • Staffan Welin Department of Medical Sciences, Endocrine Oncology Uppsala University, Uppsala, Sweden
  • Espen Thiis-Evensen Department for Organ Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway
  • Halfdan Sorbye Department of Oncology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway

DOI:

https://doi.org/10.1080/0284186X.2021.1921262

Keywords:

Diagnosis, treatment, neuroendocrine tumour, neuroendocrine carcinoma

Abstract

Background

The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.

Aim

These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group’s current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.

Downloads

Download data is not yet available.

Downloads

Published

2021-07-03

How to Cite

Tiensuu Janson, E., Knigge, U., Dam, G., Federspiel, B., Grønbaek, H., Stålberg, P., … Sorbye, H. (2021). Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Acta Oncologica, 60(7), 931–941. https://doi.org/10.1080/0284186X.2021.1921262

Issue

Vol. 60 No. 7 (2021): Acta Oncologica

Section

Articles

License

Copyright (c) 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.